Friday, September 08, 2006

Xeloda and Temodar Effective for Breast Cancer Spread to Brain

According to an article recently published in the journal Cancer, the chemotherapy combination including Xeloda® (capecitabine) and Temodar® (temozolomide) provides anticancer activity in patients with breast cancer that has spread to the brain. The brain is a common location for advanced breast cancer to spread. Unfortunately, long-term survival rates for patients with this stage of disease are not favorable. Patients are often treated with radiation therapy to the whole brain; however, this treatment may contribute to a decreased quality of life as cognitive functions can be compromised. Since many chemotherapy agents do not pass into the brain, they do not attack cancer cells that have entered the brain. Temodar, on the other hand, is a chemotherapy agent that is able to pass into the brain. Since it tends to be well tolerated, researchers continue to evaluate Temodar in the treatment of cancers that either originate in the brain or spread to the brain from other sites in the body (brain metastasis). --Click the title of this post to read the full article from its source--

0 Comments:

Post a Comment

<< Home

/* WebRing Code */